The Ministry of industry and trade of the Russian Federation sent addressed to domestic and foreign pharmaceutical companies asking to start to supply the market with labeled medications: this will help to avoid problems during the introduction of mandatory labelling in July. The letter with such contents, signed by the Deputy Minister Sergei Tsyb has received 526 companies, write “sheets”.
The government approved the introduction of mandatory labelling of medicines in Russia – 1 July 2020 From this day turnover of unmarked drugs is prohibited, and the path of goods from production to the counter to be traceable through the “Honest sign”.
To improve the quality of testing of the “Honest sign” by other market players, not just pharmaceutical companies, the Ministry recommends to fill the market of labelled products. To do this, pharmaceutical companies have to bring in about putting drugs into circulation and shipment contractors, said in a letter to the Ministry. Now pharmaceutical companies are obliged to transfer to the “Honest sign” only information about the marking on the product packaging, explained the Deputy Director of the centre for the development of promising technologies (CRPT) Revaz Yusupov.
According to him, many pharmaceutical manufacturers label drugs, but not inject them into the circulation or injected, but as untagged – no pass information about them to the system. This poses challenges for distributors and pharmacies, which are unable to fully test the system prior to the introduction of mandatory labelling on 1 July.
The Ministry instructs pharmaceutical companies not yet established in the enterprises all the necessary marking equipment to do so and to inform about the work done up to 30 April 2020.
Due to coronavirus-related constraints can not be completed, many of the procedures implementing technical solutions for new hardware and software markings. COVID is 19 amended – there were delays in supplying equipment and have difficulties with attraction of foreign specialists to configure, say representatives of many pharmaceutical manufacturers.